BANK OF AMERICA CORP /DE/ - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,100,562
+132.9%
187,211
+90.2%
0.00%
Q2 2023$2,190,379
-89.4%
98,444
-89.7%
0.00%
-100.0%
Q1 2023$20,611,591
+926.6%
951,597
+862.6%
0.00%
Q4 2022$2,007,826
-5.9%
98,859
+18.8%
0.00%
Q3 2022$2,134,000
-7.0%
83,218
-13.7%
0.00%
Q2 2022$2,294,000
-2.1%
96,468
-7.3%
0.00%
Q1 2022$2,343,000
-85.2%
104,071
-87.0%
0.00%
-100.0%
Q4 2021$15,811,000
+157.3%
798,544
+155.7%
0.00%
Q3 2021$6,146,000
+67.2%
312,278
+86.9%
0.00%
Q2 2021$3,675,000
-29.2%
167,059
-23.4%
0.00%
-100.0%
Q1 2021$5,189,000
+80.6%
218,130
+98.6%
0.00%
Q4 2020$2,873,000
+9.4%
109,838
-27.2%
0.00%
Q3 2020$2,625,000
+97.5%
150,826
+90.8%
0.00%
Q2 2020$1,329,000
+28.2%
79,033
-9.4%
0.00%
Q1 2020$1,037,000
+47.5%
87,261
+50.1%
0.00%
Q4 2019$703,000
-63.8%
58,132
-57.7%
0.00%
Q3 2019$1,944,000
+116.5%
137,535
+70.8%
0.00%
Q2 2019$898,000
-37.5%
80,531
-34.2%
0.00%
Q1 2019$1,437,000
-34.4%
122,461
-25.3%
0.00%
Q4 2018$2,190,000
+173.4%
163,924
+187.1%
0.00%
Q3 2018$801,000
-82.0%
57,101
-79.8%
0.00%
-100.0%
Q2 2018$4,453,000
-59.0%
283,316
-57.1%
0.00%
-50.0%
Q1 2018$10,855,000
+340.7%
659,857
+383.9%
0.00%
Q4 2017$2,463,000
+90.0%
136,363
+103.1%
0.00%
Q3 2017$1,296,000
+99.7%
67,126
+22.2%
0.00%
Q2 2017$649,000
+1.4%
54,951
-5.9%
0.00%
Q1 2017$640,000
+137.9%
58,403
+57.7%
0.00%
Q4 2016$269,000
+47.8%
37,035
+32.4%
0.00%
Q3 2016$182,000
+8.3%
27,972
-8.9%
0.00%
Q2 2016$168,000
+460.0%
30,692
+383.4%
0.00%
Q1 2016$30,000
+11.1%
6,349
+16.8%
0.00%
Q4 2015$27,000
+237.5%
5,438
+152.8%
0.00%
Q3 2015$8,000
-87.1%
2,151
-79.2%
0.00%
Q2 2015$62,000
+6100.0%
10,327
+7723.5%
0.00%
Q1 2015$1,000
-96.4%
132
-98.7%
0.00%
Q2 2014$28,000
+460.0%
9,824
+777.1%
0.00%
Q1 2014$5,0001,120
+13900.0%
0.00%
Q4 2013$0
-100.0%
8
-98.6%
0.00%
Q3 2013$1,000
-80.0%
580
-80.5%
0.00%
Q2 2013$5,0002,9670.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders